C/EBPbeta is a Major Regulatory Element Driving Transcriptional Activation of the CXCL12 Promoter
Overview
Molecular Biology
Authors
Affiliations
CXCL12 is considered a constitutively expressed chemokine with homeostatic functions. However, induction of CXCL12 expression and its potential role in several pathologic conditions have been reported, suggesting that CXCL12 gene expression can be induced by different stimuli. To elucidate the molecular mechanisms involved in the regulation of CXCL12 gene expression, we aim to define the molecular factors that operate at the transcriptional level. Basal, constitutive expression of CXCL12 was dependent on basic helix-loop-helix factors. Transcriptional up-regulation of the CXCL12 gene was induced by cellular confluence or inflammatory stimuli such as interleukin-1 and interleukin-6, in a CCAAT/enhancer binding protein beta (c/EBPbeta)-dependent manner. Chromatin immunoprecipitation assays confirmed c/EBPbeta binding to a specific response element located at -1171 of the promoter region of CXCL12. Our data show that c/EBPbeta is a major regulatory element driving transcription of the CXCL12 gene in response to cytokines and cell confluence.
Skeletal muscle fibers produce B-cell stimulatory factors in chronic myositis.
Carstens P, Mullar L, Wrede A, Zechel S, Wachowski M, Brandis A Front Immunol. 2023; 14:1177721.
PMID: 37731487 PMC: 10508232. DOI: 10.3389/fimmu.2023.1177721.
Emerging functions of C/EBPβ in breast cancer.
Matherne M, Phillips E, Embrey S, Burke C, Machado H Front Oncol. 2023; 13:1111522.
PMID: 36761942 PMC: 9905667. DOI: 10.3389/fonc.2023.1111522.
Roy I, Anu P, Zaunz S, Reddi S, Giri A, Sankar R iScience. 2022; 25(10):105171.
PMID: 36204266 PMC: 9530850. DOI: 10.1016/j.isci.2022.105171.
Antonova D, Zinovyeva M, Kondratyeva L, Sass A, Alekseenko I, Pleshkan V Int J Mol Sci. 2021; 22(7).
PMID: 33804861 PMC: 8038081. DOI: 10.3390/ijms22073298.
C/EBPß Isoform Specific Gene Regulation: It's a Lot more Complicated than you Think!.
Spike A, Rosen J J Mammary Gland Biol Neoplasia. 2020; 25(1):1-12.
PMID: 32078094 PMC: 7694698. DOI: 10.1007/s10911-020-09444-5.